Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction | Zendy

Are A. Kalstad | Zendy; Peder L. Myhre | Zendy; K Laake | Zendy; Sjur H. Tveit | Zendy; Erik Berg Schmidt | Zendy; P Smith | Zendy; Dennis W Nilsen | Zendy; Arnljot Tveit | Zendy; Morten Wang Fagerland | Zendy; Svein Solheim | Zendy; Ingebjørg Seljeflot | Zendy; Harald Arnesen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction

Author(s) -

Are A. Kalstad,

Peder L. Myhre,

K Laake,

Sjur H. Tveit,

Erik Berg Schmidt,

P Smith,

Dennis W Nilsen,

Arnljot Tveit,

Morten Wang Fagerland,

Svein Solheim,

Ingebjørg Seljeflot,

Harald Arnesen

Publication year - 2020

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.120.052209

Subject(s) - medicine , myocardial infarction , cardiology

High intake of marine n-3 polyunsaturated fatty acids (PUFA) has been associated with reduced risk of cardiovascular events; however, this has not been confirmed in patients with a recent acute myocardial infarction (AMI). Elderly patients are at particularly increased cardiovascular risk after myocardial infarction, but few trials address this group specifically. Omega-3 fatty acids hold the potential to reduce cardiovascular events with limited adverse effects in this vulnerable group. The hypothesis was that daily addition of 1.8g n-3 PUFA to standard of care secondary prophylaxis in elderly patients who have survived an AMI would reduce the risk of subsequent cardiovascular events during 2 years follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research